Dr. Stelios T. Andreadis's lab focuses on innovative approaches to treat neurodegenerative diseases like multiple sclerosis. They work on creating special hydrogels that help transplanted human cells survive better in a damaged brain environment. Through their research, they aim to improve cell therapies by designing better methods for delivering these cells to where they are needed most in the brain.

Chong Cheng's lab focuses on developing innovative drug delivery systems that are biodegradable and do not use polyethylene glycol (PEG), which can cause immune reactions. The team is creating novel zwitterionic polymer-drug conjugates (ZPDCs) that can effectively deliver multiple drugs, specifically targeting pancreatic cancer treatment. Their research combines chemistry and engineering to improve the safety and efficacy of drug therapies, contributing to better clinical outcomes for patients.